info icon

Infantile muscular atrophy

G6_INFAMUSC

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 G12.0
  • Hospital discharge: ICD-9 3350A
  • Hospital discharge: ICD-8 33010
  • Cause of death: ICD-10 G12.0
  • Cause of death: ICD-9 3350A
  • Cause of death: ICD-8 33010

2 out of 7 registries used, show all original rules.

23

4. Check minimum number of events

None

23

5. Include endpoints

None

23

6. Filter based on genotype QC (FinnGen only)

23

Control definitions (FinnGen only)

Control exclude
G6_NEUATR

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
G12
Name in latin
Atrophia musculorum spinalis infantilis, typus I (Werdnig-Hoffmann)

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 336 175 158
Only index persons 168 84 84
Unadjusted period prevalence (%)
Whole population 0.00 0.01 0.00
Only index persons 0.00 0.00 0.00
Median age at first event (years)
Whole population 34.82 32.08 37.34
Only index persons 48.25 42.81 53.69

-FinnGen-

Key figures

All Female Male
Number of individuals 23 12 11
Unadjusted period prevalence (%) 0.00 0.00 0.00
Median age at first event (years) 43.04 28.92 58.44

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007853) Bacteria identified in Skin by Aerobe culture
6
18
4.12
1.89
2.3
3.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
6
18
4.12
1.89
15.5
7.3
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
5
13
4.59
1.81
7.6
31.8
kpa
10.4
8.9
—
5
13
(3044889) 12 lead EKG panel
17
110
3.08
1.57
3.3
3.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
9
43
2.78
1.53
4.6
4.0
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
13
77
2.58
1.31
15.2
11.7
mmol/l
1.2
1.2
0.24
13
71
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
12
71
2.44
1.18
14.8
11.0
mmol/l
1.2
1.2
0.20
12
65
(3012544) pH of Venous blood
5
21
2.75
1.15
17.2
5.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
11
65
2.33
1.06
2.5
3.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
13
83
2.30
1.05
6.9
5.2
—
0.0
—
0
14
(3009261) Glucose [Presence] in Urine by Test strip
13
85
2.22
0.97
4.5
3.7
—
0.0
—
0
14
(3035350) Ketones [Presence] in Urine by Test strip
13
85
2.22
0.97
3.8
3.7
—
0.0
—
0
14
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
11
68
2.18
0.93
3.5
2.1
nmol/l
76.0
67.8
0.47
11
60
(40768797) Stomach Pathology biopsy report
0
27
0.00
0.83
0.0
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
5
26
2.17
0.76
6.0
2.3
ug/g
273.0
131.8
—
5
21
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
17
132
2.10
0.74
7.9
7.6
u/l
72.9
98.6
1.61
17
125
(3013826) Glucose [Moles/volume] in Serum or Plasma
14
105
1.85
0.72
7.9
4.7
mmol/l
6.5
6.7
0.14
14
97
(40758558) Short blood count panel - Blood
9
61
1.78
0.65
2.3
6.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
0
23
0.00
0.62
0.0
4.4
—
34.7
—
0
15
(3015736) pH of Urine
10
69
1.79
0.56
3.1
3.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
11
80
1.72
0.51
2.7
4.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
9
66
1.59
0.47
4.7
3.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
0
15
0.00
0.43
0.0
2.9
—
—
—
0
0
(4035726)
0
16
0.00
0.43
0.0
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
12
145
0.64
0.37
3.8
3.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
6
45
1.45
0.37
2.8
5.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
7
55
1.39
0.34
2.9
2.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
8
60
1.51
0.34
1.8
1.9
mmol/l
2.4
2.4
—
8
53
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
18
161
1.54
0.32
3.1
4.2
mmol/l
1.6
1.5
0.18
18
146
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
14
156
0.74
0.31
7.8
11.1
ml/min/173m2
98.4
87.3
—
9
122
(3037467) Urinalysis macro (dipstick) panel - Urine
15
129
1.47
0.29
4.3
4.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
14
120
1.42
0.29
5.3
3.0
u/l
56.9
49.9
0.13
14
114
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
5
38
1.40
0.25
2.4
3.9
ng/l
88.4
551.2
—
5
29
(3026008) Bacteria identified in Urine by Culture
6
47
1.37
0.23
3.0
2.9
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
0
10
0.00
0.22
0.0
3.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
10
0.00
0.22
0.0
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
10
0.00
0.22
0.0
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.22
0.0
2.8
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
0
12
0.00
0.22
0.0
2.9
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
0
12
0.00
0.22
0.0
2.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
0
14
0.00
0.21
0.0
1.5
—
152.7
—
0
14
(3019225) pH of Specimen
0
14
0.00
0.21
0.0
6.6
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
7
60
1.24
0.20
4.6
8.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
18
166
1.39
0.20
4.1
4.5
mmol/l
2.9
2.7
0.38
18
153
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
14
155
0.75
0.19
4.3
5.1
mmol/mol
37.6
39.2
0.22
14
145
(3001122) Ferritin [Mass/volume] in Serum or Plasma
9
78
1.25
0.19
5.4
2.5
ug/l
95.2
96.7
—
9
73
(3029937) Albumin [Presence] in Urine by Test strip
5
44
1.17
0.11
4.0
4.0
—
0.0
—
0
12
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
17
162
1.19
0.09
3.2
4.3
mmol/l
5.8
5.8
0.02
17
150
(3006504) Eosinophils/100 leukocytes in Blood
9
82
1.16
0.09
5.8
7.4
%
3.3
2.9
—
9
74
(3022096) Basophils/100 leukocytes in Blood
9
82
1.16
0.09
5.8
7.3
%
0.7
0.6
—
9
75
(3019069) Monocytes/100 leukocytes in Blood
9
83
1.14
0.09
5.9
7.6
%
8.0
8.2
—
9
76
(3002030) Lymphocytes/100 leukocytes in Blood
9
85
1.10
0.08
6.3
7.5
%
32.0
29.2
—
9
79
(3013707) Erythrocyte sedimentation rate by Westergren method
14
133
1.13
0.08
3.6
3.7
mm/h
13.1
10.6
0.28
14
125
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
13
127
1.05
0.00
2.8
3.5
pmol/l
15.3
14.3
1.00
13
119
(3018010) Neutrophils/100 leukocytes in Blood
9
86
1.08
0.00
6.3
7.1
%
56.2
55.5
—
9
80
(1002224) Polysomnography panel
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
7.1
—
0
5
(3005033) Fetal Nuchal fold Thickness US
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
2.2
—
0
5
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
2.0
—
260.0
—
0
7
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
0
5
0.00
0.00
0.0
2.0
—
12.8
—
0
5
(3044640) Blood type and Crossmatch panel - Blood
5
49
1.03
0.00
2.0
3.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
16
161
0.98
0.00
3.5
4.1
mu/l
1.8
2.0
0.37
16
144
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
0.2
—
0
6
(3015171) Extractable nuclear Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
5
55
0.88
0.00
10.2
2.8
mmol/l
4.4
7.9
—
5
46
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.8
—
19.0
—
0
5
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
5
50
1.00
0.00
1.0
1.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
1.3
—
0
7
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
0
5
0.00
0.00
0.0
2.6
—
125.6
—
0
5
(1761868) Lipid panel - Serum or Plasma
5
51
0.98
0.00
1.2
2.9
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
0
5
0.00
0.00
0.0
3.4
—
21.4
—
0
5
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
0
5
0.00
0.00
0.0
1.8
—
17.0
—
0
5
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
225.7
—
0
6
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
3.6
—
0
5
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint G6_INFAMUSC and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have G6_INFAMUSC.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: G6_INFAMUSC – Infantile muscular atrophy

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data